H.R. 2134: Western Hemisphere Drug Policy Commission Act of 2009

H.R. 2134

Western Hemisphere Drug Policy Commission Act of 2009

Rep. Eliot L. Engel

December 8, 2009 (111th Congress, 1st Session)

Staff Contact

Floor Situation

H.R. 2134 is expected to be considered on the floor of the House under a motion to suspend the rules, requiring a two-thirds vote for passage. The legislation was introduced by Rep. Eliot Engel (D-NY) on April 28, 2009.

Bill Summary

H.R. 2134 creates a 10-member Western Hemisphere Drug Policy Commission to provide Congress with a report that reviews U.S. drug policies and makes recommendations on ways to improve them. The bill specifies that the purpose of the commission is to review and evaluate United States illicit drug supply policy, with particular emphasis on international drug policies and programs directed toward the countries of the Western Hemisphere and demand reduction policies and programs. The Commission would identify policy and program options to improve existing international and domestic counternarcotics policy.

The commission would consist of non-elected officials appointed by House and Senate leaders, as well as the president. Their recommendations to Congress would be due one year after their first meeting. After 60 days of reporting to Congress, the authorization of the commission would sunset.

H.R. 2134 authorizes $2 million for the commission.



According to the bill's findings, the U.S. accounts for approximately 5 percent of world population and an estimated 17 percent of the world's users of illegal drugs are Americans. All of the U.S. cocaine supply and 90 percent of the United States heroin supply originates in South America. Central America, the Caribbean, and Mexico are key transit countries for drugs entering the United States.


There is no Congressional Budget Office (CBO) cost estimate available for this bill.